Dimerization of the plasma membrane Na <sup>+</sup> /H <sup>+</sup> exchanger type 3 (NHE3)
Victor Babich(The University of Texas Southwestern Medical Center), Orson W. Moe(Io Therapeutics (United States)), Igor Štagljar(University of Toronto), Olivier Bonny, Serge M. Gisler(University of Zurich), Donald W. Hilgemann, Daniel G. Fuster(University of Bern), I. Alexandru Bobulescu(Southwestern Medical Center)
Cited by 0
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
|American Journal of Kidney Diseases|2018|644
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
The Complex and Intriguing Lives of PIP2 with Ion Channels and Transporters
|Science Signaling|2001|466
The Complex and Intriguing Lives of PIP <sub>2</sub> with Ion Channels and Transporters
|Science s STKE|2001|452